Dr. Reddy's Laboratories Limited (ADR) (NYSE:RDY)
A global pharmaceutical company, which produces pharmaceutical ingredients and intermediates, finished dosage forms and biotechnology products and markets them globally. It conducts research in the areas of cancer, diabetes, cardiovascular disease etc.
- Quote
- Commentary
- Scorecard
- Historical Prices
- Chart
- Stats
- Ratios
- Earnings/Growth Rates
- Statements
- SEC Filings
Recs
IfHeDiesHeDies
(35.89)
Submitted: 4/8/2013 1:26:54 AM :
Start Price:
$34.44
RDY Score:
+2.62
A+ awesome growth potential!
Recs
pennysplants
(99.61)
Submitted: 11/22/2012 4:14:34 PM :
Start Price:
$12.54
RDY Score:
+163.24
Reaffirm long.
Recs
immlong
(65.96)
Submitted: 4/7/2012 1:52:35 AM :
Start Price:
$33.32
RDY Score:
+7.18
Too much competition in their niche, and nothing pencil to distinguish them.
Recs
Recs
desidadda
(25.29)
Submitted: 12/21/2011 9:44:41 PM :
Start Price:
$29.69
RDY Score:
-6.19
Generics rock
Recs
Omen1618
(< 20)
Submitted: 10/21/2011 10:57:19 AM :
Start Price:
$31.27
RDY Score:
-13.63
This company makes generic pharmaceuticals, ton of pharma patents coming due in the near future which provides DRL with a big upside.
Recs
dnelyo
(< 20)
Submitted: 9/10/2011 6:45:58 PM :
Start Price:
$30.26
RDY Score:
-20.51
India + pharmaceuticals = general guess into demographic growth & spending
Recs
1derway
(< 20)
Submitted: 5/27/2011 2:24:54 PM :
Start Price:
$34.75
RDY Score:
-15.89
I always buy generics! What a great company!
next 5 years eps growth 56%
peg .46!!!
Hello!
Recs
HardnoseDotCom
(74.77)
Submitted: 4/25/2011 1:31:30 PM :
Start Price:
$36.76
RDY Score:
-21.78
low PEG, strong price uptrend
Recs
frederick7
(< 20)
Submitted: 2/23/2011 12:38:15 PM :
Start Price:
$33.29
RDY Score:
-13.75
Big money!
Recs
modestus1
(< 20)
Submitted: 12/27/2010 10:49:56 PM :
Start Price:
$36.14
RDY Score:
-27.64
One of India's leading generic drug maker with a large market to expand.
Recs
dgoldenz
(24.59)
Submitted: 11/8/2010 10:35:58 AM :
Start Price:
$39.00
RDY Score:
-39.32
up, up, and away
Recs
rogervictor
(< 20)
Submitted: 10/26/2010 2:16:46 PM :
Start Price:
$36.70
RDY Score:
-37.61
With the expiration of expensive patten, generic drug manufacturers are bound to prosper. TEVA, andReddy could be the next beneficiaries.
Recs
msricekc
(77.34)
Submitted: 10/13/2010 11:37:57 AM :
Start Price:
$13.66
RDY Score:
+143.03
I sold too early.
Recs
jimrusch22
(52.12)
Submitted: 7/26/2010 3:53:37 PM :
Start Price:
$27.19
RDY Score:
-10.06
rapidy growing globally - as aggressivie a company as TEVA
Recs
AmericanGenius
(< 20)
Submitted: 6/4/2010 11:44:38 AM :
Start Price:
$29.14
RDY Score:
-23.63
India or Pharm? How about both!
Recs
LevGross
(45.08)
Submitted: 5/28/2010 9:53:01 AM :
Start Price:
$27.98
RDY Score:
-15.77
Really like this company. Major player in generics in the US and positioned in the country with the biggest growth potential. Buy this and ABB.
Recs
sanjay1969
(< 20)
Submitted: 5/28/2010 6:25:10 AM :
Start Price:
$27.90
RDY Score:
-14.92
regarding hydrocarbon industry
Recs
jahjimhall
(< 20)
Submitted: 2/23/2010 2:24:32 PM :
Start Price:
$23.53
RDY Score:
+9.10
Rising health care utilization in Asia. Expect Rupee to outperform Dollar due to unprecedented USA deficit spending, so this stock will benefit from currency movement also.
Recs
RetiredinFL08
(73.02)
Submitted: 2/17/2010 9:33:01 AM :
Start Price:
$23.32
RDY Score:
+11.24
generics from a well established pharmaceutical company in an emerging economy
RSS Headlines
Fool UK
- Show Me:
-
Outperform
-
Underperform
-
All
- Sort by:
-
Author
-
Recs
-
Date
-
Member Rating
-
Results 1 - 20 of 75 : 1 2 3 4 Next »